Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024 as against Rs 120.59 crore during the previous quarter ended June 2023. Sales declined 33.62% to Rs 230.69 crore in the quarter ended June 2024 as against Rs 347.55 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended |
| Jun. 2024 | Jun. 2023 | % Var. |
| Sales | 230.69 | 347.55 | -34 |
| OPM % | 34.65 | 48.04 | - |
| PBDT | 96.49 | 176.48 | -45 |
| PBT | 83.09 | 163.94 | -49 |
| NP | 60.77 | 120.59 | -50 |